A Comprehensive Survey Of The Governmental Hospitals Conducted In Cooperation Between The MoPH And T

التصنيف العلاجي	الاسم	أساسي / جنيسي	التركيبة العلمية	العيار	الشكل الصيدلاني	سعر المبيع من العموم
B05CX01	DEXTROSE	G	Dextrose, H2O - 10g/100ml	10g/100ml	Injectable solution	252,820 L.L
B05CX01	DEXTROSE	G	Dextrose, H2O - 10g/100ml	10g/100ml	Injectable solution	284,997 L.L
B05CX01	DEXTROSE	G	Dextrose, H2O - 10g/100ml	10g/100ml	Injectable solution	220,643 L.L
B05CX01	DEXTROSE	G	Dextrose, H2O - 20g/100ml	20g/100ml	Injectable solution	369,209 L.L
B05CX01	DEXTROSE 20% INJECTION USP	G	Glucose - 20%	20%	Injectable solution	316,025 L.L
B05CX01	DEXTROSE 20% INJECTION USP	G	Glucose - 20%	20%	Injectable solution	183,869 L.L
B05CX01	DEXTROSE	G	Dextrose, H2O - 5g/100ml	5g/100ml	Injectable solution	174,062 L.L
B05CX01	DEXTROSE	G	Dextrose, H2O - 5g/100ml	5g/100ml	Injectable solution	174,062 L.L
B05CX01	DEXTROSE	G	Dextrose, H2O - 5g/100ml	5g/100ml	Injectable solution	170,630 L.L
B05CX01	DEXTROSE	G	Dextrose, H2O - 5g/100ml	5g/100ml	Injectable solution	182,720 L.L
B05CX01	DEXTROSE	G	Dextrose, H2O - 5g/100ml	5g/100ml	Injectable solution	205,933 L.L
B05CX01	DEXTROSE 5% INJECTION, USP	G	Glucose - 5%	5%	Injectable solution	193,062 L.L
B05CX01	DEXTROSE 5% INJECTION, USP	G	Glucose - 5%	5%	Injectable solution	171,228 L.L
B05CX01	DEXTROSE 5% INJECTION, USP	G	Glucose - 5%	5%	Injectable solution	158,587 L.L
B05CX01	DEXTROSE 5% INJECTION USP	G	Glucose - 5%	5%	Injectable solution	158,587 L.L
B05CX01	DEXTROSE 5% INJECTION USP	G	Glucose - 5%	5%	Injectable solution	171,228 L.L
B05CX01	DEXTROSE INJECTION 5%	G	Dextrose, H2O - 5g/100ml		Injectable solution	212,797 L.L
B05CX01	DEXTROSE	G	Dextrose, H2O - 5g/100ml	5g/100ml	Injectable solution	188,772 L.L
B05CX01	DEXTROSE	G	Dextrose, H2O - 5g/100ml	5g/100ml	Injectable solution	188,772 L.L
B05CX01	DEXTROSE	G	Dextrose, H2O - 5g/100ml	5g/100ml	Injectable solution	195,361 L.L
B05CX01	DEXTROSE	G	Dextrose, H2O - 5g/100ml	5g/100ml	Injectable solution	224,565 L.L
B05CX01	DEXTROSE	G	Dextrose, H2O - 5g/100ml	5g/100ml	Injectable solution	185,340 L.L
H02AB01	DIPROFOS	B	Betamethasone (dipropionate) - 5mg/ml, Betamethasone (sodium phosphate) - 2mg/ml		Injectable suspension	446,156 L.L
H02AB04	DEPO MEDROL	B	Methylprednisolone acetate - 40mg/ml	40mg/ml	Injectable suspension	182,763 L.L
H02AB04	DEPO MEDROL	B	Methylprednisolone acetate - 80mg/2ml	80mg/2ml	Injectable suspension	365,525 L.L
J07CA11	DIPHTHERIA, TETANUS,PERTUSSIS, HEPATITIS B AND HAEMOPHILUS INFLUENZAE TYPE B CONJUGATE VACCINE	B	Diphteria Toxoid1 - ?25Lf (?30IU)/0.5ml, Tetanus toxoid1 - ?2.5Lf (?40IU)/0.5ml, Bordetella pertussis (Whole cell) - ?16OU (?4.0IU)/0.5ml, HBs Antigen (r DNA)1 - ?10mcg/0.5ml, H. Influenza type b, purified capsular polysaccharide2 - 10mcg/0.5ml, 1 adsorbed on aluminium phosphate, Al+++ - ?1.25mg , 2 conjugated to tetanos toxoid carrier protein -		Injectable suspension	1,515,854 L.L
R01AA07	DECOZAL	G	Xylometazoline HCl - 0.1%	0.1%	Metered dose spray	147,823 L.L
R01AA07	DECOZAL	G	Xylometazoline HCl - 0.05%	0.05%	Metered dose spray	155,886 L.L
R01AA07	DECOZAL	G	Xylometazoline HCl - 0.05%	0.05%	Metered dose spray	108,851 L.L
C05BX51	DOXIPROCT	B	Calcium dobesilate - 4%, Lidocaine HCl - 2%		Ointment	610,104 L.L

اجراء مسح شامل للمستشفيات الحكومية بالتعاون بين وزارة الصحة العامة والتفتيش المركزي